scholarly journals Determination of Specific Anti - Toxocara Antibodies in Patients with Cardiac Disease

2021 ◽  
Vol 9 (3) ◽  
pp. 36
Author(s):  
Eleonora Kaneva ◽  
Rumen Harizanov ◽  
Stefka Krumova ◽  
Petya Genova-Kalu ◽  
Iskra Rainova ◽  
...  
Keyword(s):  
Heart Disease ◽  
Western Blot ◽  
Cardiac Disease ◽  
Igg Antibodies ◽  
Serological Study ◽  
Serum Samples ◽  
Primary Screening ◽  
Inflammatory Heart Disease ◽  
Disease Specific

Aim of this study is to find the seroprevalence of specific anti - Toxocara IgG antibodies among patients with inflammatory heart disease and to evaluate the significance of this parasite as a possible etiological agent of such pathology. We performed a serological study of 41 patients with heart disease (myocarditis, pericarditis and endocarditis) for presence of specific anti-Toxocara IgG antibodies. We used ELISA for primary screening, and Western blot as a confirmatory method. Presence of specific anti-Toxocara IgG antibodies in ELISA was detected in three (7.3%) of the serum samples, and another two (4.9%) were with borderline values. These serum samples were further examined in Western blot and three of them (7.3%) displayed disease-specific bands. We do not in any way claim that in these cases Toxocara infection is the cause of inflammatory heart disease, but the data from the study shows that such a link is possible.

An Acridinium Ester for Determination of Serum Arylesterase Activity in Patients with Coronary Heart Disease

2013 ◽  
Vol 781-784 ◽  
pp. 812-817
Author(s):  
Yu Hua Gong ◽  
Xiao Jing Mu ◽  
Zhi Tao Chen ◽  
Zulipiyan Abulimite ◽  
Min Liu ◽  
...  
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Chronic Diseases ◽  
Negative Correlation ◽  
Phenyl Acetate ◽  
Serum Samples ◽  
Significant Difference ◽  
Acridinium Ester

Paraoxonase (PON) is a hydrolyase correlated with many chronic diseases. The use of 9-(4-chlorophenyloxycarbonyl)-10-methylacridinium triflate ester (CPOCMA) as a substrate for determination of serum arylesterase PON activity had been reported. It is meaningful to compare this substrate with phenyl acetate further with serum samples of patients with coronary heart disease (CHD, n=104). Correlations of PON arylesterase activity with CHD and also with age were analyzed. There was no significant difference in serum arylesterase activity (based on the CPOCMA or the phenyl acetate) between of the CHD inpatients and controls at same age level (45-60 years old). Statistically negative correlation of serum PON CPOCMAase activity (p=0.020) but not the activity based on phenyl acetate (p>0.05) with age was observed. Based on the both substrates, significant decrease in PON activity was found in the old CHD inpatients (≥60 years old), compared with that in the young CHD inpatients (<60 years old), or with that in the young controls. The methods based on CPOCMA substrate and based on the phenyl acetate demonstrated consistent results in correlation with CHD, but different results in correlation of PON activity with age.

scholarly journals Diagnostic-test evaluation of immunoassays for anti-Toxoplasma gondii IgG antibodies in a random sample of Mexican population

2014 ◽  
Vol 8 (05) ◽  
pp. 642-647 ◽  
Author(s):  
Heriberto Caballero-Ortega ◽  
Rocío Castillo-Cruz ◽  
Sandra Murieta ◽  
Luz Belinda Ortíz-Alegría ◽  
Esther Calderón-Segura ◽  
...  
Keyword(s):  
Toxoplasma Gondii ◽  
Western Blot ◽  
Latin American ◽  
High Sensitivity ◽  
Reference Standards ◽  
Igg Antibodies ◽  
Serum Samples ◽  
Serological Tests ◽  
Western Blots ◽  
Open Population

Introduction: There are few articles on evaluation of Toxoplasma gondii serological tests. Besides, commercially available tests are not always useful and are expensive for studies in open population. The aim of this study was to evaluate in-house ELISA and western blot for IgG antibodies in a representative sample of people living in Mexico. Methodology: Three hundred and five serum samples were randomly selected from two national seroepidemiological survey banks; they were taken from men and women of all ages and from all areas of the country. ELISA cut-off was established using the mean plus three standard deviations of negative samples. Western blots were analysed by two experienced technicians and positivity was established according to the presence of at least three diagnostic bands. A commercial ELISA kit was used as a third test. Two reference standards were built up: one using concordant results of two assays leaving the evaluated test out and the other in which the evaluated test was included (IN) with at least two concordant results to define diagnosis. Results: the lowest values of diagnostic parameters were obtained with the OUT reference standards: in-house ELISA had 96.9% sensitivity, 62.1% specificity, 49.6% PPV, 98.1% NPV and 71.8% accuracy, while western blot presented 81.8%, 89.7%, 84.0%, 88.2% and 86.6% values and the best kappa coefficient (0.72-0.82). Conclusions: The in-house ELISA is useful for screening people of Mexico, due to its high sensitivity, while western blot may be used to confirm diagnosis. These techniques might prove useful in other Latin American countries.

scholarly journals Comparison of diagnostic accuracy for eight SARS-CoV-2 serological assays

2021 ◽  
Vol 31 (1) ◽  
pp. 121-133
Author(s):  
Andrea Tešija Kuna ◽  
Marijana Miler ◽  
Mario Štefanović ◽  
Ivan Šamija ◽  
Josipa Periša ◽  
...  
Keyword(s):  
Diagnostic Accuracy ◽  
Severe Disease ◽  
Comparison Study ◽  
Igg Antibodies ◽  
Serum Samples ◽  
Serological Tests ◽  
Perfect Agreement ◽  
Significant Difference ◽  
Polymerase Chain

Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serological tests have been suggested as an additional diagnostic tool in highly suspected cases with a negative molecular test and determination of seroprevalence in population. We compared the diagnostic performance of eight commercial serological assays for IgA, IgM, and IgG antibodies to the SARS-CoV-2 virus. Materials and methods: The comparison study was performed on a total of 76 serum samples: 30 SARS-CoV-2 polymerase chain reaction (PCR)- negative and 46 SARS-CoV-2 PCR-positive patients with asymptomatic to severe disease and symptoms duration from 3-30 days. The study included: three rapid lateral flow immunochromatographic assays (LFIC), two enzyme-linked immunosorbent assays (ELISA), and three chemiluminescence immunoassays (CLIA). Results: Agreement between IgM assays were minimal to moderate (kappa 0.26 to 0.63) and for IgG moderate to excellent (kappa 0.72 to 0.92). Sensitivities improved with > 10 days of symptoms and were: 30% to 89% for IgM; 89% to 100% for IgG; 96% for IgA; 100% for IgA/IgM combination; 96% for total antibodies. Overall specificities were: 90% to 100% for IgM; 85% to 100% for IgG; 90% for IgA; 70% for IgA/IgM combination; 100% for total antibodies. Diagnostic accuracy for IgG ELISA and CIA assays were excellent (AUC ≥ 0.90), without significant difference. IgA showed significantly better diagnostic accuracy than IgM (P < 0.001). Conclusion: There is high variability between IgM assays independently of the assay format, while IgG assays showed moderate to perfect agreement. The appropriate time for testing is crucial for the proper immunity investigation.

scholarly journals Study of eosinophil cationic protein serum levels in patients with toxocariasis

2020 ◽  
Vol 2 (3) ◽  
pp. 178-182
Author(s):  
Eleonara Marinova Kaneva ◽  
◽  
Rumen Nenkov Harizanov ◽  
Iskra Georgieva Rainova ◽  
Iskren Tsvetkov Kaftandjiev ◽  
...  
Keyword(s):  
Eosinophil Cationic Protein ◽  
Serum Levels ◽  
Disease Stage ◽  
Confirmatory Test ◽  
Ocular Involvement ◽  
Igg Antibodies ◽  
Serum Samples ◽  
Recent Infection ◽  
Cationic Protein

Introduction: Toxocariasis is a zoonotic helminth infection with difficult diagnosis. Determination of specific IgG antibodies alone does not allow to establish the disease stage and to evaluate the treatment efficacy. Therefore it is necessary to identify additional markers that will assist the diagnosis. The purpose of our study was to identify and monitor eosinophil cationic protein (ECP) levels in patients with toxocariasis confirmed by serology and to compare our data with the literature to determine the relevance of this protein as an indicator for recent infection and the effectiveness of the therapy. Material and methods: ELISA (CUSABIO) commercial kit was used for determination of ECP concentration. Sixty serum samples were studied from individuals previously tested and confirmed for toxocariasis by the presence of specific anti-Toxocara IgG antibodies in ELISA (Toxocara IgG Rbiopharm) and the presence of specific bands in Western blot as confirmatory test (LD BIO). Twenty serum samples from clinically healthy blood donors were used as a control group. Results: The mean concentration of serum ECP in the patients with toxocariasis was significantly higher than in clinically healthy subjects. Seventy-two percent of patients affected by toxicariasis showed increased serum concentration of ECP. However, no statistically significant differences were observed in terms of age (p = 0.451) and sex (p = 0.682) of the patients or clinical form of the disease. ECP levels among patients with visceral toxocariasis were relatively higher (mean 22.99 ng / ml ± 13.16 SD) in comparison to those with ocular involvement (15.60 ng/ml ± 9.92 SD). Correlation between the presence of peripheral eosinophilia and the concentration of serum ECP was not also established. Conclusion: Data from our study give us reason to believe that serum levels of ECP could serve as an additional marker indicating recent infection, especially in patients without marked increase in the blood eosinophils.

scholarly journals Identification and Pilot Evaluation of Salivary Peptides from Anopheles albimanus as Biomarkers for Bite Exposure and Malaria Infection in Colombia

2020 ◽  
Vol 21 (3) ◽  
pp. 691 ◽  
Author(s):  
Berlin Londono-Renteria ◽  
Papa M. Drame ◽  
Jehidys Montiel ◽  
Ana M. Vasquez ◽  
Alberto Tobón-Castaño ◽  
...  
Keyword(s):  
Disease Risk ◽  
Mosquito Species ◽  
Igg Antibodies ◽  
Anopheles Albimanus ◽  
Serum Samples ◽  
Igg Antibody ◽  
Quantitative Immunoassay ◽  
Risk Of Disease ◽  
Antibody Levels

Insect saliva induces significant antibody responses associated with the intensity of exposure to bites and the risk of disease in humans. Several salivary biomarkers have been characterized to determine exposure intensity to Old World Anopheles mosquito species. However, new tools are needed to quantify the intensity of human exposure to Anopheles bites and understand the risk of malaria in low-transmission areas in the Americas. To address this need, we conducted proteomic and bioinformatic analyses of immunogenic candidate proteins present in the saliva of uninfected Anopheles albimanus from two separate colonies—one originating from Central America (STECLA strain) and one originating from South America (Cartagena strain). A ~65 kDa band was identified by IgG antibodies in serum samples from healthy volunteers living in a malaria endemic area in Colombia, and a total of five peptides were designed from the sequences of two immunogenic candidate proteins that were shared by both strains. ELISA-based testing of human IgG antibody levels against the peptides revealed that the transferrin-derived peptides, TRANS-P1, TRANS-P2 and a salivary peroxidase peptide (PEROX-P3) were able to distinguish between malaria-infected and uninfected groups. Interestingly, IgG antibody levels against PEROX-P3 were significantly lower in people that have never experienced malaria, suggesting that it may be a good marker for mosquito bite exposure in naïve populations such as travelers and deployed military personnel. In addition, the strength of the differences in the IgG levels against the peptides varied according to location, suggesting that the peptides may able to detect differences in intensities of bite exposure according to the mosquito population density. Thus, the An. albimanus salivary peptides TRANS-P1, TRANS-P2, and PEROX-P3 are promising biomarkers that could be exploited in a quantitative immunoassay for determination of human-vector contact and calculation of disease risk.

scholarly journals Multiplex Point-of-Care Tests for the Determination of Antibodies after Acellular Pertussis Vaccination

Diagnostics ◽  
2020 ◽  
Vol 10 (4) ◽  
pp. 187
Author(s):  
Aapo Knuutila ◽  
Carita Rautanen ◽  
Jussi Mertsola ◽  
Qiushui He
Keyword(s):  
Point Of Care ◽  
Vaccine Antigen ◽  
Igg Antibodies ◽  
Serum Samples ◽  
Test Platform ◽  
New Type ◽  
Point Of Care Tests ◽  
Spatial Multiplex ◽  
Diagnostic Outcome

Most of the current serological diagnosis of pertussis is based on pertussis toxin (PT) IgG antibodies and does not differentiate between vaccination and infection-induced antibodies. PT is included in all of acellular pertussis vaccines available in the world. Multiplex testing of non-vaccine antigen-related antibodies has the potential to improve the diagnostic outcome of these assays. In this study, we developed a quantitatively spatial multiplex lateral flow immunoassay (LFIA) for the detection of IgG antibodies directed against PT, pertactin (PRN), and filamentous hemagglutinin (FHA). The assay was evaluated with serum samples with varying anti-PT, anti-PRN, and anti-FHA IgG levels and the result was compared to those obtained with standardized ELISA. The developed assay showed good specificity with PT and PRN antibodies and semiquantification throughout the antigen combinations. This exploratory study indicates that the multiplex LFIA is specific and sensitive, and a similar test platform with alternative antigens could be suitable for new type of pertussis serology.

The Dtermination of Paracetamol by HPLC Validation of the Method and Application on Serum Samples

2018 ◽  
Vol 69 (3) ◽  
pp. 627-631 ◽  
Author(s):  
Viorica Ohriac (Popa) ◽  
Diana Cimpoesu ◽  
Adrian Florin Spac ◽  
Paul Nedelea ◽  
Voichita Lazureanu ◽  
...  
Keyword(s):  
Mobile Phase ◽  
High Performance ◽  
Hplc Analysis ◽  
Emotional Experience ◽  
Optimum Conditions ◽  
Serum Samples ◽  
Liquid Chromatograph ◽  
Mobile Phase Flow Rate ◽  
Quantification Limit

Pain is defined as a disagreeable sensory and emotional experience related to a tissue or potential lesion. Paracetamol (Acetaminophen) is the most used non-morphine analgesic. For the determination of paracetamol we developed and validated the high performance liquid chromatography (HPLC) analysis using a Dionex Ultimate 3000 liquid chromatograph equipped with a multidimensional detector. After determining the optimum conditions of analysis (80/20 water / acetonitrile mobile phase, flow rate 1.0 mL / min, detection wavelength 245 nm) we validated the method following the following parameters: linearity of response function, linearity of results, limit (LD = 0.66 mg / mL) and quantification limit (LQ = 2.00 mg / mL), and precision. The method of determining paracetamol by HPLC was applied to 30 samples of serum collected from patients who had pain and were treated with paracetamol.

Simultaneous Determination of Chloroquine and Pyrimethamine with Cetirizine in an Active Form and Human Serum by RP-HPLC

2021 ◽  
Author(s):  
Hina Shamshad ◽  
Ali Sayqal ◽  
Jahan Zeb ◽  
Agha Zeeshan Mirza
Keyword(s):  
Human Serum ◽  
Simultaneous Determination ◽  
Active Form ◽  
Internal Standard ◽  
Hplc Method ◽  
Serum Samples ◽  
Rp Hplc ◽  
Cetirizine Hydrochloride ◽  
Bulk Drug

Abstract A simple, accurate and precise RP-HPLC method was developed for the simultaneous determination of chloroquine, pyrimethamine and cetirizine hydrochloride concentrations in bulk drug and human serum. The assay was performed using a mobile phase of methanol: water (70:30) at pH of 2.8 ± 0.05 on the Purospher C-18 column with UV detection at 230 nm and rosuvastatin used as an internal standard. The retention times observed for chloroquine, pyrimethamine and cetirizine hydrochloride were 3.5, 2.5 and 5.5 minutes, respectively. The method was found to be specific for the assayed drugs showing a linear response in the concentration range of 1–100 μg mL−1 with coefficients of determination values of (r = 0.999). The method was developed and validated according to ICH guidelines. The method was used to monitor the serum samples and was found to be sensitive for therapeutic purposes, showing the potential to be a useful tool for routine analysis in laboratories.

Sign in / Sign up

Export Citation Format

Share Document